The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...

The US Food and Drug Administration on Tuesday released approximately 100 warning letters it had sent to drug companies on September 9, alleging that the companies made false or misleading claims on ...

Companies’ false advertisements and other deceptive business practices can have significant adverse commercial consequences for their competitors. Along with short-term loss of business, misleading ...

Marketers must make sure they’re clued up about what they can and can’t say when promoting their brand. Ellen Forrest-Charde, partner at Squire, Sanders & Dempsey LLP, examines the common pitfalls ...

The Advertising Standards Council of India (AscI) has introduced draft guidelines for labelling AI-generated content in advertising, aiming to protect consumers through a risk-based transparency ...